Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| Weiss Ratings | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.40 | |||
| 52-Week Low Price | $0.40 | |||
| 52-Week Low Price (Date) | Mar 20, 2025 | |||
| 52-Week High Price (Date) | Mar 20, 2025 | |||
| Valuation | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 90.34M | |||
| Enterprise Value | 81.75M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -9.46% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.97 | |||
| Price/Book (Q) | 2.36 | |||
| Enterprise Value/Revenue (TTM) | 2.07 | |||
| Price | $0.40 | |||
| Enterprise Value/EBITDA (TTM) | -24.26 | |||
| Enterprise Value/EBIT | -15.96 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 344.55M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 64 9 869 3035 | |||
| Address | -- | |||
| Website | aroa.com | |||
| Country | New Zealand | |||
| Year Founded | 2007 | |||
| Profitability | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -12.96% | |||
| Profit Margin | -9.97% | |||
| Management Effectiveness | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.58% | |||
| Return on Equity | -- | |||
| Income Statement | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 46.44M | |||
| Total Revenue (TTM) | 46.44M | |||
| Revenue Per Share | $0.14 | |||
| Gross Profit (TTM) | 40.23M | |||
| EBITDA (TTM) | -3.96M | |||
| EBIT (TTM) | -6.02M | |||
| Net Income (TTM) | -4.63M | |||
| Net Income Avl. to Common (TTM) | -4.63M | |||
| Total Revenue Growth (Q YOY) | 24.16% | |||
| Earnings Growth (Q YOY) | 47.21% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 48.21% | |||
| Balance Sheet | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 13.94M | |||
| Cash Per Share (Q) | $0.04 | |||
| Total Current Assets (Q) | 40.72M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 58.58M | |||
| Current Ratio (Q) | 8.535 | |||
| Book Value Per Share (Q) | $0.17 | |||
| Total Assets (Q) | 67.26M | |||
| Total Current Liabilities (Q) | 4.77M | |||
| Total Debt (Q) | 4.38M | |||
| Total Liabilities (Q) | 8.68M | |||
| Total Common Equity (Q) | 58.58M | |||
| Cash Flow | AROAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 9.74M | |||
| Cash from Financing (TTM) | -729.30K | |||
| Net Change in Cash (TTM) | 5.87M | |||
| Levered Free Cash Flow (TTM) | -7.72M | |||
| Cash from Operations (TTM) | -3.01M | |||
